156 related articles for article (PubMed ID: 7698053)
1. A comparison of fish oil or corn oil supplements in hyperlipidemic subjects with NIDDM.
Morgan WA; Raskin P; Rosenstock J
Diabetes Care; 1995 Jan; 18(1):83-6. PubMed ID: 7698053
[TBL] [Abstract][Full Text] [Related]
2. Fish oil supplementation versus gemfibrozil treatment in hyperlipidemic NIDDM. A randomized crossover study.
Fasching P; Rohac M; Liener K; Schneider B; Nowotny P; Waldhäusl W
Horm Metab Res; 1996 May; 28(5):230-6. PubMed ID: 8738112
[TBL] [Abstract][Full Text] [Related]
3. Effects of fish oil supplementation on glucose and lipid metabolism in NIDDM.
Borkman M; Chisholm DJ; Furler SM; Storlien LH; Kraegen EW; Simons LA; Chesterman CN
Diabetes; 1989 Oct; 38(10):1314-9. PubMed ID: 2676659
[TBL] [Abstract][Full Text] [Related]
4. Effect of fish oil versus corn oil supplementation on LDL and HDL subclasses in type 2 diabetic patients.
Petersen M; Pedersen H; Major-Pedersen A; Jensen T; Marckmann P
Diabetes Care; 2002 Oct; 25(10):1704-8. PubMed ID: 12351465
[TBL] [Abstract][Full Text] [Related]
5. Long-term effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia.
Rivellese AA; Maffettone A; Iovine C; Di Marino L; Annuzzi G; Mancini M; Riccardi G
Diabetes Care; 1996 Nov; 19(11):1207-13. PubMed ID: 8908381
[TBL] [Abstract][Full Text] [Related]
6. Dose-dependent effects of docosahexaenoic acid supplementation on blood lipids in statin-treated hyperlipidaemic subjects.
Meyer BJ; Hammervold T; Rustan AC; Howe PR
Lipids; 2007 Mar; 42(2):109-15. PubMed ID: 17393216
[TBL] [Abstract][Full Text] [Related]
7. Blood pressure lowering in elderly subjects: a double-blind crossover study of omega-3 and omega-6 fatty acids.
Margolin G; Huster G; Glueck CJ; Speirs J; Vandegrift J; Illig E; Wu J; Streicher P; Tracy T
Am J Clin Nutr; 1991 Feb; 53(2):562-72. PubMed ID: 1989427
[TBL] [Abstract][Full Text] [Related]
8. Effect of fish oil concentrate on lipoprotein composition in NIDDM.
Schectman G; Kaul S; Kissebah AH
Diabetes; 1988 Nov; 37(11):1567-73. PubMed ID: 3181646
[TBL] [Abstract][Full Text] [Related]
9. Fish Oil Supplements Lower Serum Lipids and Glucose in Correlation with a Reduction in Plasma Fibroblast Growth Factor 21 and Prostaglandin E2 in Nonalcoholic Fatty Liver Disease Associated with Hyperlipidemia: A Randomized Clinical Trial.
Qin Y; Zhou Y; Chen SH; Zhao XL; Ran L; Zeng XL; Wu Y; Chen JL; Kang C; Shu FR; Zhang QY; Mi MT
PLoS One; 2015; 10(7):e0133496. PubMed ID: 26226139
[TBL] [Abstract][Full Text] [Related]
10. The independent and combined effects of aerobic exercise and dietary fish intake on serum lipids and glycemic control in NIDDM. A randomized controlled study.
Dunstan DW; Mori TA; Puddey IB; Beilin LJ; Burke V; Morton AR; Stanton KG
Diabetes Care; 1997 Jun; 20(6):913-21. PubMed ID: 9167099
[TBL] [Abstract][Full Text] [Related]
11. Normal subjects consuming physiological levels of 18:3(n-3) and 20:5(n-3) from flaxseed or fish oils have characteristic differences in plasma lipid and lipoprotein fatty acid levels.
Layne KS; Goh YK; Jumpsen JA; Ryan EA; Chow P; Clandinin MT
J Nutr; 1996 Sep; 126(9):2130-40. PubMed ID: 8814201
[TBL] [Abstract][Full Text] [Related]
12. A controlled study on the effects of n-3 fatty acids on lipid and glucose metabolism in non-insulin-dependent diabetic patients.
Annuzzi G; Rivellese A; Capaldo B; Di Marino L; Iovine C; Marotta G; Riccardi G
Atherosclerosis; 1991 Mar; 87(1):65-73. PubMed ID: 1872925
[TBL] [Abstract][Full Text] [Related]
13. Long-term effects of fish oil on lipoprotein subfractions and low density lipoprotein size in non-insulin-dependent diabetic patients with hypertriglyceridemia.
Patti L; Maffettone A; Iovine C; Marino LD; Annuzzi G; Riccardi G; Rivellese AA
Atherosclerosis; 1999 Oct; 146(2):361-7. PubMed ID: 10532692
[TBL] [Abstract][Full Text] [Related]
14. Effects of a small quantity of omega-3 fatty acids on cardiovascular risk factors in NIDDM. A randomized, prospective, double-blind, controlled study.
Axelrod L; Camuso J; Williams E; Kleinman K; Briones E; Schoenfeld D
Diabetes Care; 1994 Jan; 17(1):37-44. PubMed ID: 8112187
[TBL] [Abstract][Full Text] [Related]
15. Effects of fish oil supplements in NIDDM subjects. Controlled study.
Hendra TJ; Britton ME; Roper DR; Wagaine-Twabwe D; Jeremy JY; Dandona P; Haines AP; Yudkin JS
Diabetes Care; 1990 Aug; 13(8):821-9. PubMed ID: 2209315
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the effects of n-3 fatty acids from linseed oil and fish oil in well-controlled type II diabetes.
McManus RM; Jumpson J; Finegood DT; Clandinin MT; Ryan EA
Diabetes Care; 1996 May; 19(5):463-7. PubMed ID: 8732710
[TBL] [Abstract][Full Text] [Related]
17. Effect of dietary fish oil on plasma lipoprotein cholesterol in rats fed a diet enriched in cholesterol and sucrose.
Chiang MT; Tsai ML
Int J Vitam Nutr Res; 1997; 67(3):196-200. PubMed ID: 9202981
[TBL] [Abstract][Full Text] [Related]
18. Fish oil supplementation in type 2 diabetes: a quantitative systematic review.
Montori VM; Farmer A; Wollan PC; Dinneen SF
Diabetes Care; 2000 Sep; 23(9):1407-15. PubMed ID: 10977042
[TBL] [Abstract][Full Text] [Related]
19. Corn oil improves the plasma lipoprotein lipid profile compared with extra-virgin olive oil consumption in men and women with elevated cholesterol: results from a randomized controlled feeding trial.
Maki KC; Lawless AL; Kelley KM; Kaden VN; Geiger CJ; Dicklin MR
J Clin Lipidol; 2015; 9(1):49-57. PubMed ID: 25670360
[TBL] [Abstract][Full Text] [Related]
20. Lipid, lipoprotein, and hemostatic effects of fish vs fish-oil n-3 fatty acids in mildly hyperlipidemic males.
Cobiac L; Clifton PM; Abbey M; Belling GB; Nestel PJ
Am J Clin Nutr; 1991 May; 53(5):1210-6. PubMed ID: 1826986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
